InflaRx NV
XETRA:IF0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InflaRx NV
XETRA:IF0
|
DE |
|
Mediclinic International PLC
LSE:MDC
|
UK |
|
Wild Bunch AG
F:WBAH
|
DE |
|
Keynes Technology Co Ltd
OTC:IPEU
|
US |
|
S
|
Shui On Land Ltd
F:OL5
|
CN |
|
J
|
Jinyu Bio-Technology Co Ltd
SSE:600201
|
CN |
|
D
|
Derwent London PLC
SWB:DVK
|
UK |
|
Doro AB
F:DR8A
|
SE |
|
B
|
Buzzi Unicem SpA
F:UCM
|
IT |
|
Helvetia Holding AG
SIX:HELN
|
CH |
|
G
|
GuocoLand (Malaysia) Bhd
KLSE:GUOCO
|
MY |
|
S
|
Sun Yad Construction Co Ltd
TWSE:1316
|
TW |
|
Heidrick & Struggles International Inc
NASDAQ:HSII
|
US |
|
N
|
New Tech Venture SA
WSE:NTV
|
PL |
|
Y
|
Yuanta 13 Special Acquisition Company Co Ltd
KOSDAQ:449020
|
KR |
|
Fatfish Group Ltd
ASX:FFG
|
AU |
|
C
|
Chariot Ltd
XBER:C62
|
GG |
|
S
|
Single Well Industrial Corp
TPEX:3490
|
TW |
|
P
|
Prospect Resources Ltd
OTC:PRSTF
|
AU |
|
X
|
XXL ASA
F:2XX
|
NO |
|
Cyberloq Technologies Inc
OTC:CLOQ
|
US |
|
Nano Mobile Healthcare Inc
OTC:VNTH
|
US |
|
R
|
Rathdowney Resources Ltd
XTSX:RTH
|
CA |
Wall St Price Targets
IF0 Price Targets Summary
InflaRx NV
According to Wall Street analysts, the average 1-year price target for
IF0 is 10.309 EUR with a low forecast of 3.889 EUR and a high forecast of 18.866 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IF0's stock price target?
Price Target
10.309
EUR
According to Wall Street analysts, the average 1-year price target for
IF0 is 10.309 EUR with a low forecast of 3.889 EUR and a high forecast of 18.866 EUR.
What is the Revenue forecast for InflaRx NV?
Projected CAGR
253%
The compound annual growth rate for Revenue over the next 8 years is 253%.